Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iniparib in BRCA-associated ovarian cancer
NCT00677079Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of iniparib in epithelial ovarian cancer (EOC), fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Sanofi. Started Jun 2008; status: completed.
02
Drugs
iniparib
03
Conditions
epithelial ovarian cancer (EOC)fallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00677079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00677079.